OBJECTIVE: The aim of this randomized controlled trial for patients with advanced cancer receivingradiation therapy was to determine the effect of a multidisciplinary intervention on spiritual quality of life (QOL) at the end of the intervention (week 4) and at two follow-up time points (weeks 26 and 52). METHODS:One hundred thirty-one persons were randomized to either the intervention or control (forms only) groups. The intervention included six 90-min in-person sessions based on the physical, emotion, social, and spiritual domains of QOL. Three sessions included the spiritual component. Caregivers were present for four sessions, one which included a spiritual component. Ten follow-up phone calls were made to the patients in the intervention group during the 6-month follow-up period. Patients completed the Functional Assessment of Cancer Therapy: General Scale, the Linear Analog Self-Assessment which includes an assessment of spiritual QOL, and the Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being (FACIT-Sp) at enrollment, and weeks 4, 27, and 52. RESULTS: Following the intervention, the intervention group demonstrated improved spiritual QOL on the FACIT-Sp, whereas the spiritual QOL of the control group decreased, resulting in significant mean changes between groups (total score: 1.7 vs. -2.9; p < 0.01; meaning/peace subscale: 1.0 vs. -3.5; p < 0.01; faith subscale: 3.1 vs. -1.7; p = 0.04). CONCLUSIONS: The results indicate that a multidisciplinary intervention which includes a spiritual component can maintain the spiritual QOL of patients with advanced cancer during radiation therapy.
RCT Entities:
OBJECTIVE: The aim of this randomized controlled trial for patients with advanced cancer receiving radiation therapy was to determine the effect of a multidisciplinary intervention on spiritual quality of life (QOL) at the end of the intervention (week 4) and at two follow-up time points (weeks 26 and 52). METHODS: One hundred thirty-one persons were randomized to either the intervention or control (forms only) groups. The intervention included six 90-min in-person sessions based on the physical, emotion, social, and spiritual domains of QOL. Three sessions included the spiritual component. Caregivers were present for four sessions, one which included a spiritual component. Ten follow-up phone calls were made to the patients in the intervention group during the 6-month follow-up period. Patients completed the Functional Assessment of Cancer Therapy: General Scale, the Linear Analog Self-Assessment which includes an assessment of spiritual QOL, and the Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being (FACIT-Sp) at enrollment, and weeks 4, 27, and 52. RESULTS: Following the intervention, the intervention group demonstrated improved spiritual QOL on the FACIT-Sp, whereas the spiritual QOL of the control group decreased, resulting in significant mean changes between groups (total score: 1.7 vs. -2.9; p < 0.01; meaning/peace subscale: 1.0 vs. -3.5; p < 0.01; faith subscale: 3.1 vs. -1.7; p = 0.04). CONCLUSIONS: The results indicate that a multidisciplinary intervention which includes a spiritual component can maintain the spiritual QOL of patients with advanced cancer during radiation therapy.
Authors: Matthew M Clark; Teresa A Rummans; Pamela J Atherton; Andrea L Cheville; Mary E Johnson; Marlene H Frost; Janis J Miller; Jeff A Sloan; Karen M Graszer; Jean G Haas; Jean M Hanson; Yolanda I Garces; Katherine M Piderman; Maria I Lapid; Pamela J Netzel; Jarrett W Richardson; Paul D Brown Journal: Cancer Date: 2012-08-28 Impact factor: 6.860
Authors: M Bretscher; T Rummans; J Sloan; J Kaur; A Bartlett; L Borkenhagen; C Loprinzi Journal: Psychosomatics Date: 1999 Jul-Aug Impact factor: 2.386
Authors: Teresa A Rummans; Matthew M Clark; Jeff A Sloan; Marlene H Frost; John Michael Bostwick; Pamela J Atherton; Mary E Johnson; Gail Gamble; Jarrett Richardson; Paul Brown; James Martensen; Janis Miller; Katherine Piderman; Mashele Huschka; Jean Girardi; Jean Hanson Journal: J Clin Oncol Date: 2006-02-01 Impact factor: 44.544
Authors: Keith G Wilson; Harvey Max Chochinov; Christine J McPherson; Katerine LeMay; Pierre Allard; Srini Chary; Pierre R Gagnon; Karen Macmillan; Marina De Luca; Fiona O'Shea; David Kuhl; Robin L Fainsinger Journal: J Clin Oncol Date: 2007-05-01 Impact factor: 44.544
Authors: D F Cella; D S Tulsky; G Gray; B Sarafian; E Linn; A Bonomi; M Silberman; S B Yellen; P Winicour; J Brannon Journal: J Clin Oncol Date: 1993-03 Impact factor: 44.544
Authors: Katherine M Piderman; Simon Kung; Sarah M Jenkins; Terin T Euerle; Timothy J Yoder; Gracia M Kwete; Maria I Lapid Journal: Curr Oncol Rep Date: 2015-02 Impact factor: 5.075
Authors: Crystal L Park; James E Pustejovsky; Kelly Trevino; Allen C Sherman; Craig Esposito; Mark Berendsen; John M Salsman Journal: Cancer Date: 2019-04-29 Impact factor: 6.860
Authors: Catherine E Mosher; Ekin Secinti; Shelley A Johns; Bert H O'Neil; Paul R Helft; Safi Shahda; Shadia I Jalal; Victoria L Champion Journal: Qual Life Res Date: 2017-06-10 Impact factor: 4.147
Authors: Lisa M Gudenkauf; Matthew M Clark; Paul J Novotny; Katherine M Piderman; Shawna L Ehlers; Christi A Patten; Lise Solberg Nes; Kathryn J Ruddy; Jeff A Sloan; Ping Yang Journal: Clin Lung Cancer Date: 2019-06-19 Impact factor: 4.785
Authors: Laurie E McLouth; C Graham Ford; James E Pustejovsky; Crystal L Park; Allen C Sherman; Kelly Trevino; John M Salsman Journal: Psychooncology Date: 2020-10-12 Impact factor: 3.894
Authors: D M Hansra; K McIntyre; J Ramdial; S Sacks; C S Patrick; J Cutler; B McIntyre; K Feister; M Miller; A K Taylor; F Farooq; J Antunez de Mayolo; E Ahn Journal: Evid Based Complement Alternat Med Date: 2018-04-12 Impact factor: 2.629